Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07224087
PHASE1

Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

Sponsor: Yale University

View on ClinicalTrials.gov

Summary

The purpose of this research study is to develop and pilot a multiple health behavior change intervention for weight loss and smoking cessation using medication (Naltrexone + Bupropion) and behavior therapy in adults seeking bariatric surgery.

Official title: Development of a Multiple Health Behavior Change Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-03-02

Completion Date

2027-12-31

Last Updated

2026-03-19

Healthy Volunteers

No

Interventions

DRUG

Naltrexone Hydrochloride

Participants will be given 50mg/day of Naltrexone for 4 months.

DRUG

Bupropion HCl Extended Release

Participants will be given 300mg/day of Bupropion for 4 months. Bupropion will be taken twice daily (150mg in the morning, followed by 150mg in the late afternoon/early evening).

BEHAVIORAL

Cognitive-Behavioral Therapy

Participants will receive cognitive-behavioral therapy for weight loss and smoking cessation. Participants will meet with their assigned study clinician weekly for 60 minutes for 4 months.

Locations (1)

Yale University

New Haven, Connecticut, United States